Evaluating the effects of two medications for high blood pressure

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the efficacy and safety of the combined use of AD-227A and AD-227B in treating patients with essential hypertension. Participants will receive either the active medications or placebos to determine the effectiveness of the treatment regimen. The study is designed to gather data on how well these medications work together and their safety profile in a Phase 3 setting. The trial will involve a diverse group of patients who meet specific inclusion criteria.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Signed informed consent
* Patients with Essential Hypertension
* Other inclusions applied

Exclusion Criteria:

* Patient with Secondary Hypertension
* Other exclusions applied

Where it's running

• Gangnam CHA Medical Center
  Seoul, South Korea Recruiting

Study contacts

• Principal investigator: Chong-Jin Kim — Gangnam CHA Medical Center
• Study coordinator: JeongEun Park
• Email: parkje@addpharma.co.kr
• Phone: +82-31-891-6989

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Isometric wall squat exercise to lower blood pressure in adults with hypertension

  We’re testing whether doing isometric wall squats at home for 12 weeks can help lower 24-hour blood pressure in adults with essential hypertension.

  Recruiting Korea University Guro Hospital · Seoul, Seoul · NCT07868822

• MWX401 Injection in healthy adults and people with mild hypertension

  This early Phase 1 study tests a single subcutaneous dose of MWX401 to see if it's safe and tolerable in healthy Chinese adults and in adults with mild high blood pressure.

  Recruiting Phase 1 Shanghai Minwei Biotechnology Co., Ltd · Nanjing, Jiangsu · NCT07803835

• Single-use intravascular ultrasound (IVUS) ablation for primary hypertension

  This will test whether a single-use intravascular ultrasound ablation device can safely lower blood pressure in adults with primary (essential) hypertension who are on a standardized ARB/CCB-based medication regimen.

  Recruiting at 15 sites Lepu Medical Technology (Beijing) Co., Ltd. · Beijing, Beijing Municipality and 17 other locations · NCT07051811

• Study of childhood high blood pressure and its genetic factors

  This study is trying to find out how genes affect high blood pressure in kids by looking at their health over several years to help create better treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06778239

• CKD-202A (sacubitril/valsartan) for adults with high blood pressure

  This trial will test whether CKD-202A (sacubitril/valsartan) controls blood pressure safely in adults with essential hypertension compared with valsartan.

  Recruiting Phase 3 Chong Kun Dang Pharmaceutical · Wŏnju · NCT06643819

• Treatment for severe high blood pressure using targeted artery blockage

  This study is testing a new procedure to see if blocking specific arteries can help people with severe high blood pressure that hasn't improved with regular medications.

  Recruiting Second Affiliated Hospital of Nanchang University · Nanchang · NCT06568640

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.